lauric acid has been researched along with Pancreatic Neoplasms in 1 studies
dodecanoic acid : A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Takagi, T | 1 |
Fujiwara-Tani, R | 1 |
Mori, S | 1 |
Kishi, S | 1 |
Nishiguchi, Y | 1 |
Sasaki, T | 1 |
Ogata, R | 1 |
Ikemoto, A | 1 |
Sasaki, R | 1 |
Ohmori, H | 1 |
Luo, Y | 1 |
Bhawal, UK | 1 |
Sho, M | 1 |
Kuniyasu, H | 1 |
1 other study available for lauric acid and Pancreatic Neoplasms
Article | Year |
---|---|
Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma.
Topics: Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; DNA, Mitochondrial; Drug R | 2023 |
Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma.
Topics: Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; DNA, Mitochondrial; Drug R | 2023 |
Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma.
Topics: Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; DNA, Mitochondrial; Drug R | 2023 |
Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma.
Topics: Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; DNA, Mitochondrial; Drug R | 2023 |